Tyler Technologies (TYL) has seen significant share price weakness despite reported revenue and net income growth, prompting a re-evaluation of its valuation. While popular narratives suggest the stock is overvalued with a fair value of $157.05, Simply Wall St's Discounted Cash Flow (DCF) model indicates a fair value of $447.84, suggesting it could be undervalued. The article encourages investors to analyze the underlying assumptions and financial models to form an independent view on TYL's true worth.

Johnson & Johnson (NYSE:JNJ) presented significant clinical trial results at ASCO 2026 covering autoimmunity, oncology, and myeloma, with promising data for nipocalimab in SLE and Sjögren's disease, and practice-changing Phase 3 outcomes in prostate cancer and myeloma. These updates reinforce the company's pipeline and add substance to its stock performance, which has seen a 53.9% increase over the past year. Investors should monitor the progress of these therapies toward regulatory filings and commercialization.

The article suggests investing in Southern Company (SO), an established utility with a strong dividend and current revenue from data center expansion, over Oklo (OKLO), a pre-revenue nuclear company with an $11 billion market cap and significant operating losses. Southern Company's financials show solid growth driven by data centers, whereas Oklo's first power delivery is years away, and its ventures rely on non-binding letters of intent.

Ethena Labs is diversifying the backing of its synthetic dollar, USDe, by evaluating tokenized AAA-rated Collateralized Loan Obligations (CLOs). This move aims to reduce dependence on crypto-native yield strategies and attract institutional capital by incorporating traditional finance instruments like the Janus Henderson Anemoy AAA CLO Fund (JAAA). The strategy includes a $310 million cap per position to manage liquidity and concentration risk, building on Ethena's existing positions in BlackRock's BUIDL tokenized Treasury fund.

Solventum Corporation (NYSE: SOLV) has settled a class-action lawsuit regarding its by-laws, agreeing to pay $120,000 in attorney fees without admitting wrongdoing. The lawsuit, filed by Eric Gilbert, challenged advance notice and stockholder nomination provisions, leading Solventum to amend its by-laws on September 20, 2024. This resolution removes litigation risk and aims to make corporate governance more shareholder-friendly, though investors are advised to monitor future governance updates.

Two former FirstEnergy Corp. executives, Charles "Chuck" Jones and Michael Dowling, have been reindicted in Ohio on 22 new criminal counts related to a $60 million corruption scheme, following a mistrial earlier this year. Ohio Attorney General Dave Yost stated the reindictment includes additional facts not previously known. Both men are accused of engaging in a pattern of corrupt activity, bribery, conspiracy, tampering with evidence, and telecommunications fraud, with Jones also facing obstruction of justice charges and Dowling additional tampering with records counts.

Vestcor Inc increased its stake in Lam Research Corporation by 5.9% in the fourth quarter, bringing its total holdings to $13.51 million. Analysts maintain a "Moderate Buy" rating with a consensus price target of $303.30, following strong quarterly results and a declared dividend. Despite insider selling, the semiconductor company is seen as a leader with potential upside, though some warn of its rich valuation.

WINTON GROUP Ltd initiated a new position in TechnipFMC plc, purchasing 175,965 shares valued at approximately $7.84 million in the fourth quarter. This move is part of a broader trend of high institutional ownership in TechnipFMC, with several other major firms also increasing their stakes. Analysts maintain a "Moderate Buy" rating for the stock, with an average target price of $69.71, following the company's positive quarterly earnings and revenue growth.

Westfield Capital Management Co. LP reduced its stake in FormFactor by 56.2% in the fourth quarter, selling 577,053 shares, though other major institutions like Goldman Sachs and Norges Bank increased their positions. Despite this sale, institutional investors hold 98.76% of the stock. FormFactor reported strong quarterly results, surpassing EPS estimates and achieving significant year-over-year revenue growth, with analysts maintaining a "Moderate Buy" rating and a target price of $132.45.

A Moomoo user expresses gratitude towards Moomoo and states their intention to stay long with the platform, specifically mentioning the "Leverage Shares 2x Long FUTU Daily ETF (FUTG.US)". The post is a brief personal testimonial made within the Moomoo community, highlighting a positive user experience.